hotspot -WSS

hotspot

author：hotspot 2025-09-30 00:47:24 - browse：297

James Comer -- coverage from STAT — Rep. James Comer, chair of the House Oversight Committee Kevin Dietsch/Getty Images

WASHINGTON — Congress wants to reform PBM business practices to help lower the cost of medicines — but don’t think they’ve forgotten drugmakers have a role in high drug prices.

Two lawmakers, including a Republican, questioned PhRMA Chief Operating Officer Lori Reilly about just how much her group was spending on its major campaigns against PBMs this year. Both Reps. Summer Lee (D-Pa.) and Eric Burlison (R-Mo.) used their time to question drugmakers over their spending on lawsuits against Medicare drug price negotiation and ad campaigns against pharmacy benefit managers.

Although Lee started off bashing PBMs for the fees they charge drugmakers, she quickly aimed her fire back on pharma. She said brand drugmakers charge Americans double what they charge other countries, and she asked why several drugmakers are suing the federal government over Medicare’s drug price negotiation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： CRISPR technology availability, affordability needs to be expanded

WSS

Medical devices makers are asking for forgiveness, not permission

Mirador, a new biotech startup, launches with $400 million

A new ‘biological computer' targets cancer while sparing healthy cells

Pfizer, Moderna say biotech, pharma drug development is a sprint

Stanford president’s abrupt resignation sparks debate

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

focus

hotspot

focus

Medicare details structure of new drug price negotiation program

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

How to save PrEP access — and even expand it

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Bright Health sells Medicare Advantage business to Molina

Biotech investment managers search for lucrative opportunities

Walensky prepares to leave CDC — and Congress — behind

There’s a way to spot data fakery. All journals should be using it

ChatGPT in medicine: STAT answers readers' burning questions

Readout Newsletter: Illumina, CRISPR, Regeneron

hotspot

The stock market has soared this year, but will it last? Experts weigh in

Stanford president’s abrupt resignation sparks debate

Stanford president’s abrupt resignation sparks debate

Extensive review finds private equity owners jack up cost of care

In rare move, senator releases unverified FBI source report alleging Biden bribe

Medicare Advantage insurers pressure Biden for bigger payments

explore

hotspot

Wikipedia

Wikipedia